MedTrace Logo

Comparison of Two Dose Strengths of Selexipag in Healthy Adults

NCT02745860 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-03

No results posted yet for this study

Summary

Clinical study in healthy adult subjects to compare the adult tablet of selexipag with the tablet developed for children.

Conditions

  • Healthy Subjects

Interventions

DRUG

Selexipag (adult formulation)

One selexipag film-coated tablet of 200 µg

DRUG

Selexipag (pediatric formulation)

Four selexipag film-coated tablets of 50 µg

Sponsors & Collaborators

  • Actelion

    lead INDUSTRY

Principal Investigators

  • Margaux Boehler · Actelion

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745860 on ClinicalTrials.gov